caprolactone has been researched along with simvastatin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bader, RR; Bruch, D; Gahtan, V; Gruessner, AC; Helkin, A; Maier, KG; Wilson, DR | 1 |
Banella, S; Cantù, L; Clementino, AR; Colombo, G; Del Favero, E; Pellegrini, G; Sonvico, F | 1 |
2 other study(ies) available for caprolactone and simvastatin
Article | Year |
---|---|
Intraluminal Delivery of Simvastatin Attenuates Intimal Hyperplasia After Arterial Injury.
Topics: Administration, Oral; Animals; Caproates; Carotid Artery Injuries; Carotid Artery, Common; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Drug Carriers; Drug Compounding; Humans; Hyaluronic Acid; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lactones; Micelles; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Polymers; Rats, Sprague-Dawley; Sialic Acids; Simvastatin; Tunica Intima; Vascular Remodeling | 2019 |
Structure and Fate of Nanoparticles Designed for the Nasal Delivery of Poorly Soluble Drugs.
Topics: Administration, Intranasal; Animals; Biocompatible Materials; Biological Transport; Caproates; Cell Line; Cell Survival; Chitosan; Drug Liberation; Humans; Hyaluronic Acid; Lactones; Lecithins; Nanocapsules; Nanoparticle Drug Delivery System; Nasal Mucosa; Particle Size; Polysorbates; Rabbits; Simvastatin; Solubility; Surface-Active Agents; Swine | 2021 |